201. [A Case of Advanced Gastric Cancer Who Peritoneal Dissemination but Survived over 40 Months with Locoregional Therapies].
- Author
-
Murayama M, Murakami S, Nakashima O, Yamazaki K, Koizumi K, Miyazawa M, Asaka S, Yamaguchi K, Yokomizo H, Shiozawa S, Yoshimatsu K, Shimakawa T, Katsube T, and Naritaka Y
- Subjects
- Antineoplastic Combined Chemotherapy Protocols, Gastrectomy, Humans, Male, Middle Aged, Neoplasm Recurrence, Local, Peritoneum, Peritoneal Neoplasms secondary, Stomach Neoplasms pathology, Stomach Neoplasms surgery
- Abstract
Several recent case reports have demonstrated long survival cases of advanced gastric cancer(AGC)patients suffering from peritoneal dissemination(PD)treatedwith effective chemotherapy; however, these AGC patients have poor prognosis in general. We report a case of AGC who hadsurvivedPD over 40 months with locoregional therapies. A 58-year-oldmale underwent distal gastrectomy for AGC with localized PD. Although we recommended postoperative chemotherapy, he chose surveillance as his will. Eighteen months postoperatively, CT scan revealedrecurrence of PD, andPET -CT showedonly one site of recurrent nodule. The patient chose locoregional therapy, ie, resection of the recurrent nodule instead of chemotherapy. Pathological exam confirmedthe recurrence of AGC, andabd ominal lavage cytology was classifiedas V. Even after these pathological findings, the patient refused to receive chemotherapy. At 39 months postoperatively, he developed subileus due to multiple recurrence of PD. At 40 months postoperatively, we performedchemotherapy because locoregional therapy was not supposedto be appropriate for these multiple lesions. However, the patient movedto another hospital after 1 course of chemotherapy because of his continuedrefusal to receive chemotherapy.
- Published
- 2018